You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKesson
AstraZeneca
Harvard Business School
Merck

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Patent: 7,955,809

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,955,809
Title:Method for measuring human megalin
Abstract: This invention provides a method for measuring human megalin that can be performed in a simpler manner within a shorter period of time than is possible with conventional techniques, and that can also quantify human megalin. This invention also provides a method that enables diagnosis of functional diseases, which are specific to cells, tissues, or organs, in a site-directed manner at an early stage. Measurement of human megalin enables detection of a disease in an organ in which megalin expression is observed.
Inventor(s): Ogasawara; Shinya (Niigata, JP), Miura; Shuhei (Niigata, JP), Saito; Akihiko (Niigata, JP), Takeda; Tetsuro (Niigata, JP)
Assignee: Niigata University (Niigata, JP) Denka Seiken Co., Ltd. (Tokyo, JP)
Application Number:12/293,992
Patent Claims:see list of patent claims

Details for Patent 7,955,809

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Start Trial Niigata University (Niigata, JP) Denka Seiken Co., Ltd. (Tokyo, JP) 2026-03-28 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Start Trial Niigata University (Niigata, JP) Denka Seiken Co., Ltd. (Tokyo, JP) 2026-03-28 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Start Trial Niigata University (Niigata, JP) Denka Seiken Co., Ltd. (Tokyo, JP) 2026-03-28 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Start Trial Niigata University (Niigata, JP) Denka Seiken Co., Ltd. (Tokyo, JP) 2026-03-28 RX Orphan search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 003 1978-01-16   Start Trial Niigata University (Niigata, JP) Denka Seiken Co., Ltd. (Tokyo, JP) 2026-03-28 DISCN search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Boehringer Ingelheim
McKesson
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.